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The current article provides a brief summary of biopsychosocial gender differences in alcohol 
use disorder (AUD), then reviews existing literature on gender differences in treatment 
access, retention, outcomes, and longer-term recovery. Among psychotherapies for AUD, 
there is support for the efficacy of providing female-specific treatment, and for female-only 
treatment settings but only when female-specific treatment is included. However, despite 
mandates from the National Institutes of Health to do so, there is little work thus far that 
directly compares genders on outcomes of specific psychotherapies or pharmacotherapies 
for AUD. Although existing research has mixed findings on sex and gender differences in 
overall outcomes, there are more consistent findings suggesting different mechanisms 
of behavior change among men and women in AUD treatment and long-term recovery. 
Thus, more work is needed that attends to gender and sex differences, including planning 
studies that are structured to examine not only gender-differentiated outcomes in treatment 
response, but equally important, differences in treatment access and attendance as well 
as differences in mechanisms of change in drinking behavior. 
KEY WORDS: sex; gender; treatment; recovery; alcohol; substance use disorder; mechanisms
INTRODUCTION
Between 1994 and 2017, the National Institutes 
of Health (NIH) issued mandates that biomedical 
researchers include female participants in clinical 
research,1 analyze sex/gender differences in 
NIH Phase III clinical trials,2 and submit the 
results from these analyses to Clinicaltrials.gov.3 
Additionally, between 1992 and 2010, the NIH 
Office of Research on Women’s Health strategic 
plan identified sex difference research as a 
focus in basic science, as well as incorporation 
of sex difference findings in treatment for girls 
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and women.4,5 These U.S. national policies and 
strategic plans have had a profound impact on 
treatment development for alcohol use disorder 
(AUD) by accelerating attention to sex and gender 
differences in research, resulting in increased 
awareness of gender-specific treatment needs. 
Currently, evidence-based, female-specific 
AUD treatments are emerging;6 however, there 
is still insufficient research (or reporting of 
research results) on gender differences in all 
areas of research on AUD treatment and its 
implementation. 
Most recent epidemiological results indicate a 
higher prevalence among men than women of 
AUD—defined by criteria of the fifth edition of the 
American Psychiatric Association’s Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5) 
—with past-year rates of 10% among women and 
18% among men, and respective lifetime rates of 
23% and 36%.7 However, from 2000 to 2013, 
prevalence rates of 12-month DSM-IV AUD 
increased by 84% among women compared with 
35% among men.8 Thus, attention to gender 
differences in clinical research for AUD is needed, 
given the steep trajectory of gender convergence 
over the last 20 years. The current article provides 
a brief overview of gender differences in 
biological, psychological, and social aspects of 
AUD, followed by a review of the existing 
literature on gender differences in AUD treatment, 
factors that affect long-term recovery from AUD, 
and mechanisms of behavior change.
Regarding the terminology used in this 
article—“sex,” “gender,” and “recovery”—
the NIH definition of sex refers to biological 
differences between females and males in 
chromosomes, sex organs, and endogenous 
hormones, whereas gender refers to more socially 
based roles and behaviors that may vary by 
historical and cultural contexts.9 For this article, 
American Psychological Association guidelines 
are used: gender refers to women and men as 
social groups, and sex refers to the predominantly 
biological distinction between males and females.10 
Regarding recovery from AUD, there is 
currently no consensus in definition of this term. 
Historically, recovery has been associated with 
Alcoholics Anonymous as “ongoing cognitive, 
emotional, behavioral, and spiritual reconstruction 
of the sobered alcoholic”11,12 and more recently, 
“a voluntarily maintained lifestyle characterized 
by sobriety, personal health, and citizenship.”13 In 
contemporary treatment research, AUD recovery 
is generally operationalized by primary outcomes 
related to reduction in drinking, increased 
abstinence rates, and/or reduction of AUD 
symptoms. Improvements in secondary outcomes 
such as other drug use, daily functioning, 
psychiatric symptoms, physical health, and 
employment status also are often assessed in 
AUD clinical trials and are increasingly viewed 
as outcomes inherent to recovery. Some recent 
research has focused on the relative importance 
of abstinence versus reduction of drinking and 
related symptoms (primary and secondary) 
in the definition of, and clinical implications 
for, recovery.14 In the current article, the term 
“treatment outcome” is generally used in lieu of 
recovery, with the understanding that treatment 
outcome refers to both primary (drinking) and 
secondary outcome variables.
Lastly, the research reviewed in this paper uses 
diagnoses from DSM-IV and DSM-5. Whereas 
DSM-IV described two distinct disorders—
alcohol abuse and alcohol dependence—DSM-5 
combines these into a single alcohol use disorder 
(AUD) with mild, moderate, and severe 
subclassifications reflecting the number of 
symptoms met. The main criteria change from 
DSM-IV is that DSM-5 eliminates alcohol-related 
legal problems and adds alcohol craving as a 
criterion for AUD. Lastly, although the search did 
not exclude international research, the majority of 
findings reviewed are from studies conducted and/
or funded in the United States. 
3Alcohol Research: Current Reviews Vol 40 No 3 | 2020
BIOPSYCHOSOCIAL SEX 
AND GENDER DIFFERENCES 
IN ALCOHOL USE AND AUD 
Biological Sex Differences 
Physical effects of alcohol
Alcohol is consistently shown to have more 
negative effects on women’s health than men’s, 
even at weight-adjusted lower levels of alcohol 
exposure, partly due to gender differences in 
pharmacokinetics of alcohol.15 Because women 
typically have less total body water and greater 
total body fat, alcohol is more concentrated in 
women’s bodies than in the bodies of men, creating 
greater blood alcohol content at similar doses and 
weights.16 Women with AUD also are more likely 
to develop alcohol-related heart disease, cancer, 
and liver disease,17 and more overall brain atrophy 
secondary to chronic drinking.18 
Physiological stress response
Stress plays an important role in the development 
and maintenance of AUD among both men and 
women.19 Yet, alcohol-induced alterations in 
emotional and biophysiological markers of adaptive 
stress response are more common in women than 
men.20 The nature and extent of some alterations 
are also gender-specific (e.g., blunted physiological 
responses to stress cues, alcohol cues, and 
alcohol exposure; sensitized emotional response 
to stress; alterations in hormonal fluctuations).21 
Furthermore, inflammatory responses to alcohol 
exposure, stressors, and trauma are highly sex-
specific and have widespread physiological 
effects.16 Such altered responses to stress 
differentially increase risk for and/or maintain 
AUD, co-occurring emotional disorders, and/or 
secondary effects of alcohol use (such as neural 
degeneration) among men and women. 
Hormones
Sex hormones affect all body systems directly 
and indirectly, and for women there appears to be 
a reciprocal effect of alcohol on sex hormones.16 
Chronic alcohol use has been shown to affect 
testosterone levels in men,17 whereas female sex 
hormones (estradiol, progesterone, and their 
metabolites) reciprocally interact with alcohol 
use.16,22 Specifically, alcohol induces alterations 
in estrogen receptor physiology and function,16 
which may contribute to osteoporosis, sexual 
dysfunction, and infertility in women.17 Further, 
sex hormones may influence patterns of women’s 
alcohol intake.23 Research is beginning to 
elucidate the mechanisms of these interactions. 
For instance, estrogen levels may enhance the 
rewarding properties of substances and increase 
impulsive behavior, whereas progesterone 
may attenuate substance-rewarding effects.22,23 
Furthermore, decreases in progesterone may 
increase vulnerability to stress and potentiate 
stress-induced drinking.21
Psychosocial Gender Differences 
Co-occurring psychiatric conditions
Women with AUD report higher levels of co-
occurring psychiatric conditions than do men 
with AUD. Co-occurrences of mental health 
conditions with AUD were examined using data 
from two waves (2001–2002 and 2004–2005) of 
the National Epidemiologic Survey on Alcohol 
and Related Conditions (NESARC).24 Women 
were found to have higher rates of all mood and 
anxiety disorders as well as paranoid, histrionic, 
borderline, and avoidant personality disorders 
compared to men, who had higher rates of 
narcissistic and antisocial personality disorders. 
After adjusting for sociodemographic factors, 
among persons reporting alcohol abuse (not 
dependence), only major depressive disorder was 
identified to be more likely among women than 
men. Recent research by Karpyak et al. found that 
women with AUD, compared to men with AUD, 
had higher rates of lifetime major depression, 
substance-induced depression, anxiety disorder, 
and post-traumatic stress disorder (PTSD) 
and were more likely to drink alcohol when 
experiencing negative emotion.25 Further, among 
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U.S. military veterans with AUD, women report 
more co-occurring mental health and substance 
use disorders than do men.26 
Mood and coping factors 
Among individuals with AUD, women are 
more likely than men to experience alcohol 
cravings in response to daily negative emotion 
and stress.20,21,25 In a sample of adults with 
PTSD and AUD, drinking to enhance positive 
emotions was associated with alcohol use in 
both men and women, whereas drinking to cope 
with negative affect was associated with higher 
alcohol consumption in women but not men.27 
Another study reported a positive association 
of negative affect with alcohol cravings for men 
at the beginning of alcohol detoxification, but 
for women the association persisted throughout 
detoxification.28 Additionally, for women, 
more depressive symptoms at the beginning of 
detoxification were associated with more alcohol 
cravings at the end of detoxification. A third 
study also found that women were more likely 
to report high anxiety and depression at alcohol 
detoxification admission and discharge compared 
to men.29 In that study, both genders showed 
increased anxiety and depression symptoms at 
6-month follow-up, with more anxiety symptoms 
predicting men’s relapse at 12-month follow-
up and more depression symptoms predicting 
women’s relapse at 12-month follow-up.29 
Trauma exposure 
There are high rates of trauma among women 
receiving treatment for any substance use, and an 
estimated 25% to 55% of women in substance use 
treatment have PTSD.30 Trauma and acute stressors 
are causally associated with the development of 
AUD in women, via the effects of stress and trauma 
on biological processes and the likelihood of women 
with AUD to drink to cope with negative emotion 
and stress.20 One study examining childhood 
maltreatment and lifetime odds of AUD found 
that, for both genders, having a history of physical, 
sexual, and/or emotional abuse and/or physical and/
or emotional neglect was associated with higher 
odds of having a lifetime AUD.31 For women, the 
strength of the relationship between lifetime AUD 
and all types of childhood maltreatment, except 
emotional abuse, was stronger than for men. In 
addition, Heffner and colleagues found that, for 
women, severity of current trauma symptoms and 
number of lifetime traumas predicted relapse over 
the course of the study.32 No association between 
trauma and relapse was found for men. 
Social networks 
Research has found gender differences in the 
relationship between social networks, social 
support, and alcohol use. For example, compared 
to men, women with AUD are more likely to 
have a family history of AUD and a spouse with 
a history of AUD.33 Women also are less likely 
than men to have social support in their recovery.15 
This may be at least partly due to greater stigma 
related to women’s alcohol use compared to men, 
or to women’s fear of interpersonal consequences 
related to their drinking.34 Indeed, women tend 
to be more isolated in their excessive alcohol use 
and recovery.15 Men report greater social pressure 
to change their drinking behaviors than women.35 
However, a study using data from the National 
Alcohol Study between 1984 and 2010,36 with data 
from more than 32,000 people, showed changes 
over time for women. Although results did show 
that men displayed overall greater incidences 
of pressure to change across the years, there 
was also a significant cohort effect for women, 
with younger cohorts of women (i.e., born after 
1964) reporting greater social pressure to change 
drinking. Such results coincide with gender 
convergence in rates of AUD and suggest that 
there also may be an emerging convergence of 
social pressure to change drinking. The role of 
social networks in drinking is evident in predicting 
treatment outcomes, reviewed below, and is an 
important risk and maintenance factor for AUD in 
men and women—albeit in different ways. 
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Summary
Research has illuminated gender differences in 
the biopsychosocial factors contributing to the 
development of, and recovery from, AUD. The 
physical effects of alcohol are more pervasive 
for women than men, and sex-specific factors, 
such as sex hormones, have been associated 
with alcohol use. In terms of psychosocial 
differences, stress, trauma, and negative affect 
are particularly relevant contributors to alcohol 
use and development of AUD among women. 
Relatedly, there are gender differences in terms of 
rates of co-occurring mental health conditions, the 
rates of major depressive disorder among women 
with alcohol abuse being particularly high. These 
differences provide a context for understanding 
potential gender differences in AUD treatment and 






A small percentage of individuals with AUD ever 
receive treatment, with past-year estimates of 7% 
of men and 5% of women with AUD receiving 
treatment37 and lifetime estimates of 22% to 
23% for men and 15% for women.38,39 There are 
several female-specific barriers to accessing 
AUD treatment, such as external and internalized 
stigma, lack of childcare, and systemic barriers.6 
Women are more likely than men to believe 
their alcohol problem will resolve on its own.6 
Additionally, women who are of minority racial 
or ethnic groups, of different sexual orientations, 
in the criminal justice system, living in rural 
areas, and/or of older age and women who 
speak languages other than English represent 
intersectional identities that add barriers to 
treatment entry.40 
Among individuals who do enter AUD 
treatment, there are gender differences in clinical 
presentation. Women tend to have more severe 
alcohol and drug use histories, lower education 
and income, higher unemployment and housing 
needs, more children living at home, and higher 
parental stress, and they tend to be younger in 
age.15 Primary care settings are a useful portal 
for AUD treatment access, and for women even 
more so.41 Research consistently has found that 
women access AUD treatment via portals other 
than specialty AUD options, tending to receive 
AUD care in mental health and primary care 
settings.6,15,16,42-44 
Treatment Retention
Data on gender differences in treatment retention 
are mixed, and most studies have been completed 
among samples with substance use disorder 
(SUD), meaning the results are not specific to 
AUD. For example, a review by Greenfield and 
colleagues reported no overall gender differences 
in SUD treatment retention but hypothesized that 
there would be different predictors and mediators 
of retention among men and women.42 Among 
both genders, treatment retention has been 
associated with higher financial resources, fewer 
mental health problems, less severe substance 
use problems, more employment, and older age. 
Female-specific factors related to SUD treatment 
retention include referral source, personal stability, 
number of children, and availability of childcare.42 
A separate study found that type of care setting 
(i.e., detoxification, residential, ambulatory) 
also may moderate care retention, with women 
more likely than men to leave a detox facility 
prematurely.45 
Treatment Outcome 
The following review on outcomes of 
psychosocial treatments for AUD focuses on 
empirically supported treatments identified by 
American Psychological Association Division 
12.46 The pharmacotherapy section focuses on 
medications approved by the U.S. Food and 
Drug Administration for treatment of AUD. 
Search terms included the treatment name (e.g., 
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“motivational interviewing” or “naltrexone”) + 
“gender” or “sex” + “alcohol.” The authors also 
searched ClinicalTrials.gov for clinical trials on 
these AUD treatments, and reviewed publications 
from large clinical trials for AUD, to determine 
whether gender differences were analyzed and 
reported. Lastly, the authors searched for and 
reviewed reports of clinical trials, literature 
reviews, or meta-analyses on specific treatments 
to identify commentary or results regarding sex 
or gender. This was done to address the fact 
that analyses not yielding any significant gender 
differences may not have been identified using 
the search terms. Thus, for some treatments the 
authors were able to comment on null gender 
difference findings. Despite the NIH mandate to 
include females in biomedical research,1,2 relatively 
few AUD treatment outcome studies have reported 
on gender as a moderator of treatment outcome. 
The more recent NIH policy mandating analysis 
and reporting of gender differences in treatment 
outcomes3 should result in deepened knowledge 
of gender differences in response to treatment and 
in gender-specific mechanisms that help explain 
treatment effects.
Psychotherapy
Motivational enhancement therapy, cognitive 
behavioral therapy for AUD, and twelve-
step facilitation
Motivational enhancement therapy (MET) 
is a psychotherapy that helps patients resolve 
their ambivalence about engaging in treatment 
and reducing or stopping their substance use. 
Cognitive behavioral therapy (CBT) is an 
approach that focuses on the reciprocal effects of 
cognitions, emotions, and behaviors that maintain 
problem drinking. In treating SUD, CBT also 
focuses on identifying and resolving factors that 
reinforce or punish the substance use behavior and 
teaching both general coping skills and coping 
skills to negotiate drinking triggers. Twelve-step 
facilitation (TSF) treatment for AUD is based 
on the traditional Alcoholics Anonymous (AA) 
12-step model and focuses on AA attendance, 
personalized spirituality, and guided introspection 
(“step work”). 
MET and CBT are among the most widely 
researched treatments for AUD;47 however, there 
has been limited research examining gender 
differences in the effects of these treatments. 
Project MATCH (Matching Alcoholism Treatment 
to Client Heterogeneity) generated studies on 
gender differences in treatment efficacy, although 
the samples of the three conditions (CBT, 
MET, and TSF) were between 70% and 80% 
male.48 Project MATCH had a gender matching 
hypothesis, positing that women receiving CBT 
would have better outcomes than women in the 
TSF condition, a difference that would be greater 
among women than men. This hypothesis was 
based on the expectation that CBT would better 
address secondary issues (such as mood and 
stress) and that TSF could exacerbate stigma and 
guilt among women.49 This hypothesis was not 
supported, with women in the TSF aftercare arm 
attending more AA meetings and reporting more 
AA involvement than men. CBT was ultimately 
not found to improve secondary issues to a greater 
extent than TSF.49 
Witkiewitz, Hartzler, and Donovan tested 
whether matching patients’ motivation level to 
CBT or MET was associated with better outcomes 
in the aftercare arm of Project MATCH.50 Men 
with lower baseline motivation and above-average 
alcohol dependence severity were found to 
drink more frequently in the MET than in CBT 
condition; the authors proposed that this more 
severe group may not have done as well in the 
lower-intensity MET treatment. Women with low 
motivation (regardless of severity, but who had 
overall fewer AUD symptoms than men), as well 
as low-motivated men with below-average AUD 
severity, reported less frequent drinking in MET 
compared to CBT. Another study on the outpatient 
arm of Project MATCH found that, compared 
with women, men showed greater increases in 
abstinence self-efficacy over time and across all 
treatment conditions.51 
A meta-analysis on controlled trials of brief 
motivational interventions examined gender 
as a moderator of treatment effect.52 The study 
was able to generate aggregate effect sizes only 
7Alcohol Research: Current Reviews Vol 40 No 3 | 2020
for two studies, which did not show evidence 
of differential response between genders. In 
a meta-analysis of 22 studies on motivational 
interviewing, only one study reported on gender 
effects, with no differences between men and 
women observed on treatment outcomes.53 A meta-
analysis of 53 randomized controlled trials (RCTs) 
testing CBT for SUD found that the percentage of 
female participants in each study was positively 
associated with effect size, suggesting that women 
may benefit more from CBT than men, but these 
results must be interpreted with caution, as women 
comprised only 29% of the total sample.54 
Alcohol behavioral couples therapy 
Couples-based approaches to the treatment of 
AUD are based in the assumptions that partners 
engage in malleable behaviors that reinforce 
and/or punish the client’s drinking behaviors, 
and that enhancing intimate relationships can 
improve problem-solving, enhance relationship 
functioning, and reduce likelihood of relapse. 
Behavioral couples therapy (BCT) and Alcohol 
BCT (ABCT) have been shown to be effective 
at increasing rates of abstinence from alcohol, 
decreasing alcohol-related problems, and 
improving relationship functioning.55,56 Only 
one study to date has directly compared BCT 
outcomes by gender: O’Farrell et al. compared 
treatment outcomes among men and women 
with AUD and their partners receiving BCT in a 
naturalistic setting (not a clinical trial).57 Results 
revealed few differences between genders, with 
large treatment effects in drinking reduction and 
small to medium effects in improved relationship 
satisfaction across the entire sample. 
Several studies have tested ABCT separately 
among samples of men and women. An early 
study among men with alcohol dependence and 
their female partners compared three conditions: 
(1) ABCT, in which the spouse attended all 
sessions that included both alcohol- and marital-
focused treatment; (2) full spousal attendance but 
alcohol-focused treatment only; and (3) minimal 
spousal involvement in alcohol-focused 
individual treatment.58 Participants in the ABCT 
condition showed greater drinking reductions 
and improvements in relationship functioning 
compared to those in the other conditions. A 
second study randomized men with AUD and 
their partners to either ABCT, ABCT and relapse 
prevention, or ABCT and AA facilitation; this 
study found no differences in outcome across 
treatment conditions but high rates of abstinence 
across all three conditions.59 
ABCT also has been tested among women 
with AUD, and one study compared ABCT to a 
treatment arm in which women received individual 
CBT for AUD.60 In that study, however, 31% of the 
women refused the couples’ study arm due to the 
need to bring their male partner.61 The women who 
did participate in ABCT had slightly more days 
abstinent and fewer heavy-drinking days at follow-
up than did women in the individual CBT arm. 
In response to women’s preference for individual 
treatment—yet recognizing the positive results 
of ABCT and the role significant others play in 
women’s drinking—a separate study compared 
ABCT to a “blended-ABCT,” in which women 
with AUD attended five sessions individually 
and seven with their male partner.62 Results 
showed equal outcomes across conditions. Thus, 
ABCT yielded excellent outcomes for men and 
women with AUD in separate studies, but gender 
differences in the effects of, and engagement in, 
ABCT have yet to be directly tested. 
Pharmacotherapy 
Three medications are currently approved by 
the U.S. Food and Drug Administration for the 
treatment of AUD: acamprosate, naltrexone, and 
disulfiram. There are important gender differences 
in their bioavailability, distribution, metabolism, 
elimination,63 and side effects,64 highlighting the 
importance of examining sex as a moderator of 
medication treatment efficacy for AUD. 
Acamprosate
A meta-analytic study examined acamprosate for 
AUD treatment separately for men and women 
from a total of 22 studies,65 some of which 
included women and some of which did not. 
8Alcohol Research: Current Reviews Vol 40 No 3 | 2020
Patient data were accessed from 1,217 women and 
4,794 men across the studies. Results showed no 
gender differences in any measure of acamprosate 
efficacy, safety, or tolerability (including 
percentage of abstinent days, heavy drinking, 
study completion, and medication compliance). 
Another study examined gender differences 
in treatment outcomes of the Combined 
Pharmacotherapies and Behavioral Interventions 
(COMBINE) study.66,67 Participants in COMBINE 
received medication management with 16 
weeks of placebo, naltrexone, acamprosate, or 
their combinations, with or without a combined 
behavioral intervention (a combination of 
empirically supported interventions from different 
therapies). Analyses showed that acamprosate was 
no more effective than placebo when separately 
analyzed in both men and women. 
Naltrexone
One of the first studies on naltrexone for AUD 
was a multicenter, placebo-controlled RCT of 
injectable naltrexone,68 with each condition 
comprising 32% women. Results showed that 
naltrexone was efficacious for men, but not 
women, in terms of reducing heavy drinking. 
Another study tested outcomes of psychotherapy 
with either oral naltrexone or placebo and found 
that naltrexone was not efficacious compared 
to placebo for female participants in reducing 
drinking, but it did delay the onset of drinking 
after an initial lapse.69 
A third study tested high-dose naltrexone 
in men and women with co-occurring cocaine 
use disorder and AUD in a double-blind placebo 
RCT.70 Participants were randomized to receive 
either naltrexone (150 mg) or placebo (58 men 
and 24 women in each condition), combined with 
either CBT or medication management. Women 
taking naltrexone used more cocaine and alcohol 
than did men and the placebo group, whereas men 
in the naltrexone group used less cocaine and 
alcohol compared to women and the male placebo 
group. The authors hypothesized that side effects 
of naltrexone (e.g., nausea, vomiting) for women 
may account for this effect. Indeed, women have 
been shown to have more negative side effects 
from naltrexone than men, which may be related 
to women’s greater sensitivity to the endogenous 
opioid system.71 Women’s sensitivity to the effects 
of naltrexone also may vary across the menstrual 
cycle, with greater sensitivity in the luteal phase 
(i.e., post-ovulatory, late phase of the cycle) 
compared to the early follicular phase (i.e., pre-
ovulatory, early phase of the cycle).72
Thus, early studies suggested naltrexone for 
AUD was not as effective for women as for men, 
or that women may experience worse side effects, 
contributing to worse outcomes. However, more 
recent research has suggested that these effects may 
be due to study characteristics such as sample size 
or outcomes assessed. Baros, Latham, and Anton 
used data from two RCTs comparing a naltrexone 
plus CBT group and a placebo plus CBT group 
and found effect sizes favoring naltrexone in men 
compared to women on some outcomes (drinks per 
drinking day), but not others (percentage of days 
abstinent, percentage of heavy drinking days).73 
A review of naltrexone RCTs among women 
suggested that the medication may have modest 
effects for women in drinking quantity and time to 
relapse, but not on drinking frequency.74 However, 
the number of studies reviewed was small, and 
additional research is needed.
A secondary analysis of COMBINE data 
tested treatment effects separately in men 
and women and found that both genders had 
better treatment response when they received 
naltrexone with either medication management or 
combined behavioral intervention (a combination 
of empirically supported interventions), in 
comparison to placebo and any other combination 
of treatments.66 The authors concluded that 
naltrexone is effective among women, and that 
studies showing noneffectiveness among women 
may be due to inadequate sample sizes. 
Disulfiram
In 2016, Agabio et al. cited the low number 
of women in clinical trials on disulfiram that 
preclude evaluation of sex differences in efficacy 
and safety.75 A search for any additional trials since 
2016 (search terms “sex” or “gender” or “women” 
+ “disulfiram”) did not yield new information 
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on sex differences in the effect of disulfiram for 
alcohol use. 
Digital and Mobile 
Treatment Technologies 
Emerging digital and mobile models of treatment 
delivery include platforms such as telehealth 
sessions via videoconference; direct access 
computer programs such as CBT4CBT;76 
smartphone applications (apps) such as the 
Addiction—Comprehensive Health Enhancement 
Support System (A-CHESS)77 to help patients 
track their drinking and provide real-time 
assistance with coping skills; and therapist text-
messaging protocols.78 
The preliminary research on access and 
use of AUD treatment via digital and mobile 
technologies suggests gender differences. For 
instance, a survey of members of an online social 
network site for women trying to resolve alcohol 
problems revealed that 47% of the site’s members 
had never tried any other form of support related 
to their drinking.79 A large survey study in the 
United Kingdom showed that women were more 
likely than men to use online recovery groups 
(but not recovery websites or apps).80 A separate 
study examining use of one social network site 
for SUD recovery also found a higher proportion 
of women than men using the site.81 Secondary 
analyses of an effectiveness trial testing a 
computer-assisted behavioral intervention 
(compared to treatment as usual) did not find 
gender to moderate the effect of treatment 
condition; however, results did show that 
acceptability of the computerized intervention 
was positively associated with abstinence among 
women, but not men.82 Digital and mobile 
treatment technology for AUD is a burgeoning 
area of research, which should include analysis 
and reporting of gender differences in both access 
and outcomes going forward. 
Summary
Existing research suggests no major gender 
differences in terms of overall outcome in 
psychosocial or pharmacological treatments for 
AUD. However, this finding is qualified by the 
small number of studies that directly test gender 
differences and the low enrollment of women 
in clinical trials. Additionally, as demonstrated 
by secondary analysis of Project MATCH, 
moderating factors such as AUD severity and 
motivation may be differentially associated with 
outcomes for men and women. 
SEX AND GENDER 
DIFFERENCES IN LONG-
TERM RECOVERY
Gender Differences and the Broader 
System of Recovery Care
Recovery is a complicated construct, ill-defined 
and historically confined to a mutual care, 12-step 
“disease model” system that considers abstinence 
as the only viable outcome.12 AUD is now 
conceptualized as a chronic, relapsing medical 
condition and is thought to require a continuum of 
care, ranging from acute stabilization to ongoing, 
post-treatment monitoring and maintenance of 
recovery, and in need of clear benchmarks of 
disease resolution.12 In this complicated context, 
gender differences in recovery historically have 
been understudied, but there are some limited 
findings, for instance, on AA use and clinical 
outcomes. As more sophisticated treatment 
approaches and definitions of target outcomes 
(including “recovery”) are developed in the field, 
there will be an accelerated need to identify 
moderating variables (including gender and other 
demographic variables) that predict treatment 
outcomes. The following sections highlight aspects 
of the intersection between gender differences and 
recovery research. 
Gender Differences and Mutual 
Help Groups
Alcoholics Anonymous, the largest and most 
popular mutual help organization available, offers 
primarily mixed-gender meetings, but also some 
single-gender meeting options (i.e., men-only, 
women-only). However, AA meeting content is 
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consistent across groups and does not necessarily 
include gender-specific content.83 One gender-
specific and secular mutual help organization is 
Women for Sobriety, which provides coping skills 
and reciprocal support for participants. 
Outcomes of single-gender versus mixed-gender 
AA meeting attendance have not been studied; 
however, studies on gender differences in treatment 
outcomes among attendees of mixed-gender AA 
have shown some significant results, including 
different moderators of attendance for men and 
women. One longitudinal study followed 466 men 
and women for 16 years who were initially untreated 
for problem drinking.84 Women were more likely 
to participate in AA, had longer stays in inpatient 
treatment for alcohol in the year after baseline, 
achieved better outcomes than men at 1 and 8 
years, and benefited more from AA attendance 
during years 2 through 8. At 16 years post-baseline, 
women were more likely than men to participate 
in treatment and in AA, to be free of drinking 
problems, to consume less alcohol, to have fewer 
DSM-IV dependence symptoms, and to report 
less drinking to cope and higher abstinence self-
efficacy;85 women were also more likely to report 
improvements in depression, friendships, problem-
solving, self-confidence, and family relationships 
and social functioning, compared to men.
 Witbrodt and Delucchi followed participation 
in AA for 7 years and found that men were more 
likely to stop attending over the 7-year period.86 
Women with higher co-occurring drug severity 
were less likely to participate in AA than were 
women with lower drug severity. Women with 
more severe psychiatric symptoms were more 
likely to attend AA than women whose symptoms 
were less severe. Lastly, men who were less 
religious and those with networks supportive of 
drinking were less likely to attend AA treatment. 
Another study that followed 96 women and 180 
men for up to 3 years found that AA membership 
increased participants’ odds of achieving a year 
of abstinence, an association that was stronger 
for women than for men.87 Comparing men and 
women in the United States and Sweden, the odds 
of AA attendance was greater for women who 
were both alcohol and drug dependent (versus just 
alcohol), and for women, the odds of AA attendance 
increased with the number of friends with whom to 
talk about personal problems.83
In sum, research on gender differences in 
outcomes of AA attendance are mixed, but the 
most consistent findings suggest women are more 
likely to stay in AA longer than men, and there may 
be different moderators (e.g., drug use, psychiatric 
comorbidity, religiosity, social networks) of the 
efficacy of AA for men and women. 
Gender Differences in Response to 
Continuing Care Interventions
In line with contemporary notions of AUD and 
SUD as chronic, relapsing diseases requiring 
a continuum of care, McKay and colleagues 
developed and tested stepped and continuing care 
interventions with various levels of intervention, 
including telephone counseling.88,89 The continuing 
care approach has implications for women with 
AUD, for whom social networks supporting 
abstinence may be particularly relevant for 
maintenance of recovery. 
In a sample of participants who used cocaine, 
most of whom were also alcohol dependent, 
McKay and colleagues found that women but not 
men benefited from telephone continuing care.89 
Further study of gender moderators revealed 
lower rates of cocaine-positive urine for women 
at 24 months, but not men, if receiving telephone 
continuing care versus treatment as usual.90 More 
work is encouraged in this area for AUD; sample 
sizes of women need to be sufficiently large to 
test for gender differences, and social support 
for abstinence and emotional support should be 
incorporated. 
Precipitants to Relapse
Sliedrecht and colleagues conducted a review of 
321 articles, published between 2000 and 2019, to 
examine the evidence for precipitants of relapse 
in AUD.91 The review focused on 37 potential 
determinants of relapse in AUD, including gender, 
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and identified the number of studies that found 
evidence for (or against) each relapse determinant. 
The review showed mixed results in terms of rates 
of relapse among men and women. Specifically, 
most studies (59%) included in the review found 
no gender differences in participants’ likelihood of 
relapse after treatment, but 41% of the studies did 
find gender differences and collectively suggested 
that women were less likely to relapse.91 
In another review, Walitzer and Dearing 
indicated that rates of alcohol relapse did not 
differ among men and women, but evidence 
did indicate different predictors of relapse by 
gender.92 For women, being married, marital 
stress, interpersonal conflict, and negative affect 
were risk factors for alcohol relapse whereas 
for men, risk factors included isolation and both 
negative and positive affect. Being married was 
identified as a protective factor for alcohol relapse 
in men, and having more children in the home 
was protective for women. The gender difference 
in marital status in relation to alcohol relapse 
(protective for men, risk factor for women) is 
worth noting, given that women are more likely 
to be married to a spouse who drinks and men 
are more likely to be married to a light or non-
drinker.92 Women also are more likely to drink to 
cope with marital conflict whereas men are more 
likely to report that their drinking contributes to 
marital conflict.92 
Various Forms of Recovery: Abstinence 
and Moderated Drinking
Gender differences in empirical studies on 
viability of non-abstinent forms of recovery 
have recently been studied. Analysis of gender 
differences in such studies needs to attend to 
different thresholds for risky or heavy drinking 
for men and women.14 Using Project MATCH 
data (30% female), four recovery profiles were 
generated at 3 years post-treatment: poor-
functioning frequent heavy drinkers, poor-
functioning infrequent heavy drinkers, high-
functioning occasional heavy drinkers, and 
high-functioning infrequent non–heavy drinkers. 
No gender differences in profile assignment were 
found.93 
In a study of three clinical trials for AUD—
including data from Project MATCH, the 
COMBINE study, and the United Kingdom 
Alcohol Treatment Trial—several baseline 
variables were tested as predictors of low-risk 
drinking; gender was not found to be predictive.94 
In a large epidemiological sample (41% female), 
gender differences in past-year likelihood of 
falling into one of six drinking patterns (ranging 
from abstinent recovery to five types of non-
abstinent recovery) were examined. Women 
were more likely than men to be in the abstinent 
recovery or asymptomatic, low-risk drinking 
categories than in the persistent AUD category. 
Additionally, women were less likely than men 
to fall into the symptomatic, high-risk drinking 
category. These results persisted after adjustment 
for daily amount of alcohol used, severity of AUD, 
illicit drug use, SUD, and anxiety/depression.95 
One study examined men and women with 
AUD between ages 55 and 77 in a private 
outpatient program.96 At 6-month follow-up, 79% 
of women reported abstinence from alcohol and 
drugs in the prior 30 days, compared to 54% 
of men. Among those not abstinent, no women 
reported heavy drinking in 30 days prior to 
follow-up, whereas non-abstinent men reported 
an average of 4 heavy-drinking days (a significant 
gender difference). 
Quality of Life During the 
Recovery Period
Issues such as co-occurring mental health 
conditions, social environment, sleep, and 
physical health are directly affected by problem 
drinking and are important independent 
outcomes reflecting quality of life (QoL). 
Literature reviews have shown that heavy 
drinking is associated with reduced QoL, which 
improves with reductions in drinking.97 There 
is some evidence that the association between 
drinking, recovery, and QoL may be moderated 
by sociodemographic constructs, including 
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gender.97 Among women with AUD, both 
abstinence and moderate consumption of alcohol 
were associated with improved QoL over a mean 
follow-up of 46 months.98 Among 82 patients with 
AUD admitted for inpatient detoxification and 
assessed at baseline and 12 weeks later, women 
with AUD reported lower QoL (general health, 
psychosocial impairment) than men with AUD.99 
These studies suggest that QoL be examined in 
gender differences to continue to address the 
relationship of QoL among women vis-à-vis 
reduction in drinking.
Summary 
Attention to gender differences among various 
forms of recovery (both in the 12-step model 
and in the treatment outcome literature)—
including examination of abstinence, reduction 
of drinking, and/or secondary outcomes—has 
yielded some interesting results, but research 
is sparse so far. Predictors of relapse appear to 
differ between men and women, with women 
being more likely to relapse in response to 
interpersonal conflict and negative affect 
whereas men are more likely to relapse in 
response to isolation and both positive and 
negative affect. Also, although being married 
is a protective factor for men, it can act as 
a risk factor of relapse for women. Having 
at least one close friend to discuss drinking 
with is differentially helpful for women. Also, 
gender differences in treatment outcome and 
maintenance may depend on the outcome of 
interest (drinking or secondary outcomes) and 
the “form of recovery” studied. 
SEX AND GENDER 
DIFFERENCES IN AUD 
MECHANISMS OF 
BEHAVIOR CHANGE 
There are several behavioral treatments now 
known to be efficacious for AUD, but there is 
almost no examination of gender differences in 
the AUD psychotherapy process and mechanisms 
of behavior change in this research literature. 
For example, the authors of this paper found 49 
articles published between 2000 and 2012 (26 
published since 2010) studying mechanisms of 
change in CBT, Motivational Interviewing, or 
MET or examining general therapeutic alliance 
as a mechanism of change. Of these 49 articles, 
22 were review or non-empirical papers and did 
not mention gender. Of the 27 empirical studies, 
seven (26%) provided no sample breakdown by 
gender, one study (4%) had an all-female sample, 
and 17 (63%) had mixed-gender samples (albeit 
11 of the 17 had samples that comprised at least 
two-thirds men). Furthermore, of these 17 mixed-
gender studies, only five (29%) mentioned gender 
at all, typically as a statistical covariate. Since 
2012, researchers have continued to examine 
mechanisms of change but generally have 
continued to ignore gender or used single-gender 
samples. 
The Women’s Recovery Group (WRG), a 
treatment for women with SUD (including AUD), 
examined mechanisms of change between men 
and women. WRG was compared to a traditional 
mixed-gender Group Drug Counseling (GDC) 
treatment in Stage I100 and Stage II101 trials. The 
pilot study and RCT results indicated that WRG 
was at least comparable to a mixed-gender, 
traditional drug counseling group. Secondary 
analyses of the pilot study and/or RCT data tested 
affiliative (supportive, positive, or empathic) 
statements as WRG mechanisms of change. 
Women in WRG emitted more affiliative 
statements compared to both genders in the GDC 
condition. Affiliative statements were made more 
in WRG than GDC and were associated with 
better drinking outcomes during and 6 months 
after treatment for women, especially in WRG.102 
Litt et al. studied Network Support Treatment 
(NST) for AUD, which is designed to help patients 
build social support networks for sobriety.103 Main 
treatment effects showed that men had a better 
treatment response than women. NST effects 
were mediated by changes in abstinence self-
efficacy and number of abstinent friends for both 
men and women. Among those receiving NST, 
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women reported less improvement in abstinence 
self-efficacy and fewer abstinent friends. Kelly 
and Hoeppner explored gender moderation of 
purported mediators, assessed at 9-month follow-
up, of the effects of AA on drinking at 15-month 
follow-up among Project MATCH participants.104 
Social self-efficacy and pro-abstainer social 
networks mediated AA’s effects on abstinence for 
both men and women, but a larger proportion of 
AA’s effect on treatment outcome was accounted 
for by these mediators for men (91%) than for 
women (57%). Additionally, although self-efficacy 
in positive social situations at 9-month follow-up 
was a mediator of the effect of AA on drinking at 
15-month follow-up for men, it was not for women. 
Alternatively, self-efficacy not to drink in negative 
affect situations was a significant mediator for 
women, but not for men. 
Recent studies have investigated potential 
mechanisms of behavior change among female-
only samples receiving CBT for AUD (see 
McCrady, Epstein, and Folkus6 for review). For 
instance, using times-series network analysis to 
examine concurrent and sequential relationships 
among several putative mechanisms of change, 
Holzhauer et al. examined mechanisms of change 
in an RCT comparing a gender-neutral to a 
female-specific CBT for women with AUD.105 
Higher self-confidence to abstain from drinking 
and increased use of alcohol-related coping skills 
were associated with less drinking in women in 
both CBT conditions. Women receiving female-
specific CBT also reduced their drinking through 
decreased sociotropy (reactivity to others) and 
increased social support for abstinence. Changes 
in autonomy (importance of one’s independence 
and personal rights) were associated with higher 
self-confidence in abstinence, use of coping skills, 
and less drinking in both conditions, suggesting 
that increasing autonomy may be a treatment 
mechanism specifically for women. 
Identifying mechanisms of behavior change 
in treatments for AUD is a critical research 
effort, as it provides an understanding of the 
active ingredients of effective treatments. 
Such an understanding provides clinicians 
information about the critical elements that 
should be provided for different populations 
and will aid dissemination of empirically based 
treatments.106,107 However, identifying such 
mechanisms has been difficult,106 and moderating 
factors, including sex and gender, may play an 
important role in how people change.
DISCUSSION
Literature on gender and sex differences in AUD 
has grown exponentially since 1994. This has 
been particularly true regarding research on 
biopsychosocial risk and maintenance factors of 
AUD and treatment entry and gender-specific 
barriers to treatment for AUD. However, there 
is room for improvement regarding analysis and 
reporting of gender differences in treatment 
response for AUD and in mechanisms of 
drinking behavior change. Past reviews of gender 
differences in treatment outcomes have found 
mixed results and little evidence for systematic 
gender differences.11,42 However, many of the 
studies covered in these reviews were completed 
among patients in treatment for other substances 
or for alcohol and other substances, not AUD 
alone. Additionally, many of the studies reviewed 
were set in naturalistic settings rather than in 
randomized and/or controlled trials, and most 
studies simply did not recruit enough females and 
did not present data on gender differences even 
when there was a subset of female participants. 
A recent review conducted by the RAND 
National Defense Research Institute examined 
24 AUD RCTs to examine gender differences 
in outcome and found mixed results, with little 
evidence for systematic gender differences in 
treatment effects across studies.108 However, 
the authors of that review also stated: “Most 
notably, despite an extensive search and thorough 
screening procedure, we found very few studies 
reporting on gender differences, which hindered 
our analyses. . . . The review showed a profound 
lack of information on presence and absence of 
gender differences. We contacted authors and 
scrutinized numerous U.S. RCTs for differential 
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effects for men and women but found very few 
relevant studies.”108 (p54) 
Our review and those by Greenfield and 
colleagues42 and Epstein and Menges15 all concur 
with this assessment—that there is not enough 
research on the topic of gender differences 
in treatment outcomes (psychotherapy or 
pharmacotherapy). There is not enough research 
on gender differences regarding the efficacy 
of specific treatments or enough research that 
examines secondary outcomes, aside from 
alcohol use, that are especially relevant to long-
term recovery (e.g., co-occurring psychological 
disorders or symptoms, physical health, QoL, 
moderated drinking). Although some research 
suggests women may have better outcomes than 
men in recovery from AUD, multiple factors—
including but not limited to sample size/percentage 
of women, severity of AUD, and motivation to 
change—may contribute to such findings and 
preclude conclusions at this point. 
As suggested by Moyer and colleagues,52 future 
work would be enhanced by clearly delineated 
hypotheses about why gender differences might 
be expected in specific treatments—both in 
terms of treatment efficacy and in terms of 
mechanisms of behavior change. There has been 
substantial research on gender differences in risk 
and maintenance factors for AUD, and there is 
expanding research on female-specific treatment 
needs and approaches.6 The field of AUD 
treatment development may be well positioned to 
use this research on gender differences to propose 
hypotheses about and, perhaps more important, 
men and women might respond differentially to 
a given treatment. For example, Project MATCH 
formulated a priori gender matching hypotheses; 
although these were not confirmed in the direction 
expected, gender differences did emerge that were 
then available to inform continued research. 
It is also important to note that even among the 
studies that examined sex and gender differences, 
the sample sizes of women were often small, and 
analyses were likely underpowered. Given the 
historical differences in prevalence of AUD among 
men and women, this may have been justifiable in 
the past. However, the convergence of prevalence 
rates for lifetime AUD among men and women no 
longer justifies such small samples of women in 
treatment. Although studies may recruit men and 
women, women often comprised less than 50% of 
the sample, which makes it difficult to examine 
gender differences. If gender is considered a 
moderating factor, there must be enough men and 
women to statistically power the examination of 
interaction effects. Thus, in conducting clinical 
trials it may be important to enroll comparable 
numbers of men and women, with sufficient 
power to properly examine gender differences.108 
This includes using gender as a variable in 
randomization and examining gender-related 
co-occurring conditions and other secondary 
outcomes. The literature highlighted in this review 
provides substantial evidence that sex and gender 
differences impact the factors that are integral to 
AUD recovery—such as frequency and intensity 
of drinking, social functioning, physical health, 
risk for relapse, and possibly mechanisms of 
change—and therefore deserves to be considered 
in recovery research as the field moves forward. 
Another consideration is single-gender 
treatment options, with female-only treatment 
most often a focus of research. This area of 
research has examined the delivery of treatment in 
a women-only setting, with or without including 
female-specific content (see McCrady et al.6 
for a review). There is evidence for differential, 
positive outcomes for treatment delivered in 
women-only versus mixed-gender settings,6,42 
but only when female-specific programming 
(i.e., content) also is provided. Thus, some argue 
that women-only treatment settings are not 
necessary, compared to mixed-gender settings, 
and at least one study of women in a residential 
treatment setting indicated that female-only 
treatment is not, at least initially, preferred by all 
female patients.109 However, consistent findings 
have suggested that women express satisfaction 
and preference for female-specific format and 
treatment content.6 Additionally, even if mixed-
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gender treatments were shown to be as good as 
or better than single-gender treatments, women-
specific treatments are likely to enhance treatment 




Gender differences in AUD treatment and 
recovery is an area in need of accelerated research. 
Specific areas of investigation are recommended: 
• An overarching factor is the low engagement 
of men and women with AUD treatment. 
Gender differences may play important roles 
in understanding how, when, where, and why 
individuals seek care for AUD.
• Emerging research on digital and mobile 
technologies needs to include equal numbers of 
female and male participants and to analyze data 
by gender. 
• Additional research is needed to test treatment 
access, retention, and outcomes for women 
versus men in primary care settings.
• Further research on gender-differentiated 
use of AA and other mutual help groups, 
and differences in treatment outcomes and 
mechanisms of change, is indicated. 
• Rigorous, randomized trials for AUD on single-
gender versus mixed-gender group settings with 
gender-specific programming are lacking. 
• Another important contextual factor is a clarified 
definition of “recovery.” Variations in treatment 
goals and non-abstinent outcomes need to be 
examined, including gender as a moderating 
variable. 
• Gender differences in secondary outcomes 
(such as co-occurring symptoms, interpersonal 
functioning, and quality of life) should be 
reported in AUD treatment outcome research. 
• Research suggests gender differences in relapse 
precipitants. Furthering our understanding 
of biological, social, and psychological 
determinants of relapse based on gender has 
implications for personalized or tailored relapse 
prevention approaches. 
• Clinical trials are mandated to recruit men and 
women, as well as analyze and report gender 
differences; however, the field needs to adhere 
more stringently to these mandates in future 
research. This involves consistent changes to 
methods such as intentional oversampling of 
women, randomization based on gender, and 
gender-specific analyses.
The research reviewed here provides ample 
reason to believe that men and women recover 
from AUD differently. It is important to test 
and report gender differences when studying 
mechanisms of change—mediators, moderators, 
and active therapeutic ingredients—in AUD 
treatments.
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